TERRASCEND CORP (TSND.CA) Fundamental Analysis & Valuation

TSX:TSNDCA88105E1088

Current stock price

0.89 CAD
-0.02 (-2.2%)
Last:

This TSND.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. TSND.CA Profitability Analysis

1.1 Basic Checks

  • TSND had negative earnings in the past year.
  • TSND had a positive operating cash flow in the past year.
  • TSND had negative earnings in 4 of the past 5 years.
  • In multiple years TSND reported negative operating cash flow during the last 5 years.
TSND.CA Yearly Net Income VS EBIT VS OCF VS FCFTSND.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100M -200M -300M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -15.47%, TSND is doing worse than 64.52% of the companies in the same industry.
  • With a Return On Equity value of -88.45%, TSND is not doing good in the industry: 77.42% of the companies in the same industry are doing better.
  • TSND's Return On Invested Capital of 6.19% is amongst the best of the industry. TSND outperforms 80.65% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for TSND is in line with the industry average of 8.64%.
Industry RankSector Rank
ROA -15.47%
ROE -88.45%
ROIC 6.19%
ROA(3y)-14.34%
ROA(5y)-17.9%
ROE(3y)-57.73%
ROE(5y)-55.06%
ROIC(3y)6.78%
ROIC(5y)N/A
TSND.CA Yearly ROA, ROE, ROICTSND.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200 -200 400 600 800

1.3 Margins

  • With a decent Operating Margin value of 15.36%, TSND is doing good in the industry, outperforming 74.19% of the companies in the same industry.
  • In the last couple of years the Operating Margin of TSND has grown nicely.
  • With a decent Gross Margin value of 51.80%, TSND is doing good in the industry, outperforming 67.74% of the companies in the same industry.
  • In the last couple of years the Gross Margin of TSND has remained more or less at the same level.
Industry RankSector Rank
OM 15.36%
PM (TTM) N/A
GM 51.8%
OM growth 3YN/A
OM growth 5Y21.4%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.5%
GM growth 5Y-0.92%
TSND.CA Yearly Profit, Operating, Gross MarginsTSND.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100 -200 -300 -400

1

2. TSND.CA Health Analysis

2.1 Basic Checks

  • TSND has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, TSND has more shares outstanding
  • TSND has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for TSND is higher compared to a year ago.
TSND.CA Yearly Shares OutstandingTSND.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
TSND.CA Yearly Total Debt VS Total AssetsTSND.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.2 Solvency

  • TSND has an Altman-Z score of -1.07. This is a bad value and indicates that TSND is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of -1.07, TSND is not doing good in the industry: 61.29% of the companies in the same industry are doing better.
  • TSND has a debt to FCF ratio of 18.60. This is a negative value and a sign of low solvency as TSND would need 18.60 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 18.60, TSND is in the better half of the industry, outperforming 61.29% of the companies in the same industry.
  • TSND has a Debt/Equity ratio of 2.16. This is a high value indicating a heavy dependency on external financing.
  • TSND has a worse Debt to Equity ratio (2.16) than 83.87% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.16
Debt/FCF 18.6
Altman-Z -1.07
ROIC/WACC0.59
WACC10.42%
TSND.CA Yearly LT Debt VS Equity VS FCFTSND.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 1.38 indicates that TSND should not have too much problems paying its short term obligations.
  • TSND's Current ratio of 1.38 is on the low side compared to the rest of the industry. TSND is outperformed by 64.52% of its industry peers.
  • A Quick Ratio of 0.95 indicates that TSND may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.95, TSND is not doing good in the industry: 67.74% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.38
Quick Ratio 0.95
TSND.CA Yearly Current Assets VS Current LiabilitesTSND.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

3

3. TSND.CA Growth Analysis

3.1 Past

  • The earnings per share for TSND have decreased by -3.70% in the last year.
  • The Revenue for TSND has decreased by -12.86% in the past year. This is quite bad
  • The Revenue has been growing by 12.01% on average over the past years. This is quite good.
EPS 1Y (TTM)-3.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%109.09%
Revenue 1Y (TTM)-12.86%
Revenue growth 3Y1.69%
Revenue growth 5Y12.01%
Sales Q2Q%-11.02%

3.2 Future

  • The Earnings Per Share is expected to grow by 16.69% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 4.42% on average over the next years.
EPS Next Y76.93%
EPS Next 2Y36.84%
EPS Next 3Y23.65%
EPS Next 5Y16.69%
Revenue Next Year0.1%
Revenue Next 2Y2.68%
Revenue Next 3Y3.13%
Revenue Next 5Y4.42%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
TSND.CA Yearly Revenue VS EstimatesTSND.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M
TSND.CA Yearly EPS VS EstimatesTSND.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 -0.2 -0.4 -0.6 -0.8 -1

2

4. TSND.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for TSND. In the last year negative earnings were reported.
  • Also next year TSND is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TSND.CA Price Earnings VS Forward Price EarningsTSND.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, TSND is valued cheaply inside the industry as 80.65% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, TSND is valued a bit cheaper than 64.52% of the companies in the same industry.
Industry RankSector Rank
P/FCF 19.88
EV/EBITDA 7.6
TSND.CA Per share dataTSND.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5

4.3 Compensation for Growth

  • A more expensive valuation may be justified as TSND's earnings are expected to grow with 23.65% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y36.84%
EPS Next 3Y23.65%

0

5. TSND.CA Dividend Analysis

5.1 Amount

  • No dividends for TSND!.
Industry RankSector Rank
Dividend Yield 0%

TSND.CA Fundamentals: All Metrics, Ratios and Statistics

TERRASCEND CORP

TSX:TSND (4/17/2026, 7:00:00 PM)

0.89

-0.02 (-2.2%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)03-12
Earnings (Next)05-07
Inst Owners39.22%
Inst Owner ChangeN/A
Ins Owners6.68%
Ins Owner ChangeN/A
Market Cap331.01M
Revenue(TTM)267.25M
Net Income(TTM)-86.23M
Analysts82.22
Price Target1.79 (101.12%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-58.73%
Min EPS beat(2)-348.18%
Max EPS beat(2)230.72%
EPS beat(4)1
Avg EPS beat(4)-188.13%
Min EPS beat(4)-614.39%
Max EPS beat(4)230.72%
EPS beat(8)1
Avg EPS beat(8)-154.88%
EPS beat(12)1
Avg EPS beat(12)-205.85%
EPS beat(16)3
Avg EPS beat(16)-297.98%
Revenue beat(2)1
Avg Revenue beat(2)-1.53%
Min Revenue beat(2)-3.35%
Max Revenue beat(2)0.28%
Revenue beat(4)1
Avg Revenue beat(4)-3.12%
Min Revenue beat(4)-6.15%
Max Revenue beat(4)0.28%
Revenue beat(8)1
Avg Revenue beat(8)-3.68%
Revenue beat(12)3
Avg Revenue beat(12)-2.59%
Revenue beat(16)3
Avg Revenue beat(16)-4.74%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)16.65%
EPS NQ rev (3m)16.65%
EPS NY rev (1m)-5.55%
EPS NY rev (3m)-5.55%
Revenue NQ rev (1m)-0.85%
Revenue NQ rev (3m)-2.4%
Revenue NY rev (1m)-1.25%
Revenue NY rev (3m)-1.77%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.91
P/FCF 19.88
P/OCF 11.25
P/B 2.48
P/tB N/A
EV/EBITDA 7.6
EPS(TTM)-0.38
EYN/A
EPS(NY)-0.09
Fwd EYN/A
FCF(TTM)0.04
FCFY5.03%
OCF(TTM)0.08
OCFY8.89%
SpS0.98
BVpS0.36
TBVpS-0.66
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -15.47%
ROE -88.45%
ROCE 8.6%
ROIC 6.19%
ROICexc 6.72%
ROICexgc 18.17%
OM 15.36%
PM (TTM) N/A
GM 51.8%
FCFM 4.56%
ROA(3y)-14.34%
ROA(5y)-17.9%
ROE(3y)-57.73%
ROE(5y)-55.06%
ROIC(3y)6.78%
ROIC(5y)N/A
ROICexc(3y)7.22%
ROICexc(5y)N/A
ROICexgc(3y)21.93%
ROICexgc(5y)N/A
ROCE(3y)9.41%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y21.07%
ROICexc growth 3YN/A
ROICexc growth 5Y23.75%
OM growth 3YN/A
OM growth 5Y21.4%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.5%
GM growth 5Y-0.92%
F-Score4
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 2.16
Debt/FCF 18.6
Debt/EBITDA 3.72
Cap/Depr 59.87%
Cap/Sales 3.5%
Interest Coverage 1.47
Cash Conversion 37.99%
Profit Quality N/A
Current Ratio 1.38
Quick Ratio 0.95
Altman-Z -1.07
F-Score4
WACC10.42%
ROIC/WACC0.59
Cap/Depr(3y)49.1%
Cap/Depr(5y)117.01%
Cap/Sales(3y)3.76%
Cap/Sales(5y)9.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%109.09%
EPS Next Y76.93%
EPS Next 2Y36.84%
EPS Next 3Y23.65%
EPS Next 5Y16.69%
Revenue 1Y (TTM)-12.86%
Revenue growth 3Y1.69%
Revenue growth 5Y12.01%
Sales Q2Q%-11.02%
Revenue Next Year0.1%
Revenue Next 2Y2.68%
Revenue Next 3Y3.13%
Revenue Next 5Y4.42%
EBIT growth 1Y43.55%
EBIT growth 3YN/A
EBIT growth 5Y35.98%
EBIT Next Year59.29%
EBIT Next 3Y25.39%
EBIT Next 5Y18.06%
FCF growth 1Y-55.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-43.27%
OCF growth 3YN/A
OCF growth 5YN/A

TERRASCEND CORP / TSND.CA Fundamental Analysis FAQ

What is the fundamental rating for TSND stock?

ChartMill assigns a fundamental rating of 2 / 10 to TSND.CA.


What is the valuation status of TERRASCEND CORP (TSND.CA) stock?

ChartMill assigns a valuation rating of 2 / 10 to TERRASCEND CORP (TSND.CA). This can be considered as Overvalued.


How profitable is TERRASCEND CORP (TSND.CA) stock?

TERRASCEND CORP (TSND.CA) has a profitability rating of 3 / 10.